CLVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Clarivate PLC (CLVT) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown some positive signals like free cash flow growth and optimistic guidance for 2026, the overall financial performance, significant debt, declining revenue, and negative sentiment from analysts and institutional investors make it a risky investment. It is better to hold off on investing in this stock until clearer positive trends emerge.
The MACD is positive and expanding, suggesting bullish momentum. However, RSI at 77.41 is in the neutral zone, and moving averages are converging, indicating no strong trend. The stock is trading near resistance levels (R1: 2.582, R2: 2.819), which could limit upward movement in the short term.
The company reported Q4 2025 free cash flow growth of 50.9% YoY and exceeded analysts' revenue and EPS estimates. Optimistic guidance for 2026 with projected adjusted EPS between $0.70 and $0.80.
Total debt of $4.47 billion remains a concern. Analysts have consistently lowered price targets, citing risks like AI disintermediation and execution challenges. Hedge fund HG Vora Capital Management sold all its shares, indicating a lack of confidence.
Clarivate's Q4 2025 financials showed a revenue decline to $617 million (-6.94% YoY), net income dropped to $3.1 million (-101.62% YoY), and EPS fell to 0 (-100% YoY). Gross margin also declined to 36.16% (-3.83% YoY). Despite these declines, free cash flow grew by 50.9% YoY, and the company provided optimistic guidance for 2026.
Analysts have a mixed to negative outlook on Clarivate. Recent price target reductions include Citi lowering to $2.80, RBC Capital to $3, and Barclays to $2.40. Concerns include AI competition, execution risks, and slow revenue growth. Stifel maintains a Buy rating with a $6 target, but this is an outlier among predominantly neutral to bearish ratings.
